Connect with us

Hi, what are you looking for?

Economy

Russian drugmaker seeks vaccine emergency use

Russia’s Gamaleya Research Institute of Epidemiology has applied for emergency use authorization for its coronavirus vaccine in the Philippines, according to the local Food and Drug Administration (FDA).

The regulator, which got the application on Jan. 7, had ordered the drugmaker to submit missing documents, FDA Director-General Eric Domingo said on Friday.

Gamaleya withdrew its application for clinical trials of its vaccine on Jan. 6, the Department of Science and Technology (DoST) said.

“Their reason was simple — they would apply for emergency use authorization so they don’t need the clinical trials here,” Science and Technology Undersecretary Rowena Guevarra told an online news briefing.

US drugmaker Pfizer, Inc. and Britain’s AstraZeneca Plc have also filed for emergency use with the FDA.

The three already have existing emergency use approvals in other countries.

Meanwhile, the DoST said China National Pharmaceutical Group Co., Ltd. (Sinopharm) had yet to decide whether to pursue clinical trials for its coronavirus vaccine in the Philippines.

“Sinopharm has yet to decide if it will conduct a clinical trial here or just apply for an emergency use authorization,” DoST Assistant Secretary Leah J. Buenda told a televised public briefing in mixed English and Filipino.

Ms. Buendia said the agency had signed a confidentiality disclosure agreement with Sinopharm even if it had not yet received any data from the Chinese drugmaker. — Vann Marlo M. Villegas and Kyle Aristophere T. Atienza

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

Latest

Economy

Economy

Benigno S.C. Aquino III, the Philippine president who tried to send corrupt officials to jail and took China to court for its island-building activities...

Economy

Personalities took to social media and their respective platforms to express their grief over the death of former President Benigno S. C. Aquino III on Thursday....

Economy

Cloud-based solutions support organizations in terms of collaboration and productivity during the current remote work challenges. As the usage of these tools continues to...

Economy

By Luz Wendy T. Noble, Reporter THE Philippines’ overall balance of payments (BoP) position posted a deficit of $1.39 billion in May, as the...

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Investing

As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Economy

US President Joseph R. Biden, Jr., will rely on ally countries to supply the bulk of the metals needed to build electric vehicles and focus on...

Economy

THE Securities and Exchange Commission (SEC) has warned the public from investing or to stop any investment in a group named Maxxprofit Computer Trading...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.



Your information is secure and your privacy is protected. By opting in you agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!